Cargando…
Antineoplastics/antiretrovirals: COVID-19, and diarrhoea due to off-label use: 3 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661820/ http://dx.doi.org/10.1007/s40278-020-86003-3 |
Ejemplares similares
-
Antineoplastics: Pancytopenia and off-label use: case report
Publicado: (2020) -
Antineoplastics/ciclesonide/favipiravir: Pancytopenia and off-label use: case report
Publicado: (2022) -
Lopinavir/ritonavir: Diarrhoea following off label use: case report
Publicado: (2021) -
Multiple drugs: Severe diarrhoea, off label use and treatment failure: case report
Publicado: (2022) -
Antineoplastics: COVID-19 infection: 3 case reports
Publicado: (2022)